Jump to ContentJump to Main Navigation
Show Summary Details

Buchner, Johannes

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred

SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

See all formats and pricing



Select Volume and Issue


Substrate Specificity and Inhibitor Studies of a Membrane-Bound Ganglioside Sialidase Isolated from Human Brain Tissue

C. Oehler / J. Kopitz / M. Cantz

Citation Information: Biological Chemistry. Volume 383, Issue 11, Pages 1735–1742, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2002.194, June 2005

Publication History

Published Online:


A gangliosidespecific sialidase that controls cellular functions such as growth, differentiation, and adhesion has been observed in a variety of cells, but its characterization proved difficult due to firm membrane attachment and lability of the purified enzyme. Here we report on the specificity toward gangliosides and susceptibility to certain inhibitors of a ganglioside sialidase solubilized and purified 5100-fold from human brain. The sialidase removed terminal sialic acids from gangliosides GM3, GM4, GD3, GD2, GD1a, GD1b, GT1b and GQ1b, but was inactive toward gangliosides with sialic acid in a branching position (as in GM1 and GM2). LysoGM3 and GD1a were good substrates, too, whereas Oacetylation of the sialic acid as in 9-OacetylGD3 caused strongly reduced cleavage. The new influenza virus drug 4-guanidino-2-deoxy-2,3- dehydroNacetylneuraminic acid (Zanamivir) exhibited an IC50 value of about 710 5 M that was in the range of the classical sialidase inhibitor 2-deoxy-2,3-dehydro Nacetylneuraminic acid; the bacterial sialidase inhibitor 4-nitrophenyloxamic acid, however, was ineffective. The glycosaminoglycans heparan sulfate, heparin, chondroitin sulfates A and B, as well as dextran sulfate and suramin, were all strongly inhibitory, suggesting that glycosaminoglycans present on the cell surface or in the extracellular matrix may influence the ability of the sialidase to alter the ganglioside composition of the membrane.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

José Abad-Rodríguez and Natalia Díez-Revuelta
Trends in Biochemical Sciences, 2015, Volume 40, Number 7, Page 385
A. Albohy, M. R. Richards, and C. W. Cairo
Glycobiology, 2015, Volume 25, Number 3, Page 284
Sandro Sonnino, Massimo Aureli, Nicoletta Loberto, Vanna Chigorno, and Alessandro Prinetti
FEBS Letters, 2010, Volume 584, Number 9, Page 1914
Sadagopan Magesh, Tohru Suzuki, Taeko Miyagi, Hideharu Ishida, and Makoto Kiso
Journal of Molecular Graphics and Modelling, 2006, Volume 25, Number 2, Page 196
D. Wipfler, G. V. Srinivasan, H. Sadick, B. Kniep, S. Arming, M. Willhauck-Fleckenstein, R. Vlasak, R. Schauer, and R. Schwartz-Albiez
Glycobiology, 2011, Volume 21, Number 9, Page 1161
Yanhong Li, Hongzhi Cao, Hai Yu, Yi Chen, Kam Lau, Jingyao Qu, Vireak Thon, Go Sugiarto, and Xi Chen
Molecular BioSystems, 2011, Volume 7, Number 4, Page 1060
Alessandro Prinetti, Vanna Chigorno, Laura Mauri, Nicoletta Loberto, and Sandro Sonnino
Journal of Neurochemistry, 2007, Volume 103, Number s1, Page 113
Robert McGlynn, Kostantin Dobrenis, and Steven U. Walkley
The Journal of Comparative Neurology, 2004, Volume 480, Number 4, Page 415

Comments (0)

Please log in or register to comment.